News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,647 Results
Type
Article (2613)
Company Profile (43)
Press Release (37990)
Multimedia
Podcasts (11)
Webinars (2)
Section
Business (14214)
Career Advice (78)
Deals (2120)
Drug Delivery (9)
Drug Development (4154)
Employer Resources (10)
FDA (444)
Job Trends (785)
News (20313)
Policy (1057)
Tag
Academia (146)
Allergies (7)
Alliances (3492)
ALS (6)
Alzheimer's disease (63)
Antibody-drug conjugate (ADC) (45)
Approvals (452)
Artificial intelligence (36)
Autoimmune disease (18)
Automation (3)
Bankruptcy (12)
Best Places to Work (476)
BIOSECURE Act (2)
Biosimilars (20)
Biotechnology (29)
Bladder cancer (10)
Brain cancer (8)
Breast cancer (52)
Cancer (382)
Cardiovascular disease (13)
Career advice (66)
Career pathing (1)
CAR-T (38)
CDC (2)
Cell therapy (93)
Cervical cancer (4)
Clinical research (3518)
Collaboration (239)
Company closure (2)
Compensation (120)
COVID-19 (186)
CRISPR (12)
C-suite (140)
Cystic fibrosis (8)
Data (501)
Denatured (6)
Depression (12)
Dermatology (1)
Diabetes (19)
Diagnostics (499)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (41)
Drug pricing (10)
Duchenne muscular dystrophy (51)
Earnings (4594)
Editorial (5)
Employer branding (1)
Employer resources (8)
Events (6530)
Executive appointments (144)
FDA (610)
Friedreich's ataxia (6)
Frontotemporal dementia (1)
Funding (196)
Gene editing (37)
Generative AI (3)
Gene therapy (64)
GLP-1 (74)
Government (162)
Guidances (24)
Healthcare (714)
HIV (3)
Huntington's disease (6)
IgA nephropathy (13)
Immunology and inflammation (37)
Immuno-oncology (16)
Indications (11)
Infectious disease (205)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (9)
Intellectual property (34)
Interviews (7)
IPO (1003)
IRA (7)
Job creations (294)
Job search strategy (62)
JPM (4)
Kidney cancer (7)
Labor market (11)
Layoffs (51)
Leadership (3)
Legal (215)
Liver cancer (6)
Longevity (5)
Lung cancer (35)
Lymphoma (13)
Machine learning (3)
Management (4)
Manufacturing (70)
MASH (17)
Medical device (317)
Medtech (320)
Mergers & acquisitions (1241)
Metabolic disorders (91)
mRNA (10)
Multiple sclerosis (26)
Neurodegenerative disease (35)
Neuropsychiatric disorders (11)
Neuroscience (184)
NextGen: Class of 2026 (353)
Non-profit (157)
Now hiring (13)
Obesity (44)
Opinion (17)
Ovarian cancer (22)
Pain (30)
Pancreatic cancer (24)
Parkinson's disease (14)
Partnered (4)
Patents (62)
Patient recruitment (44)
Peanut (1)
People (5944)
Pharmaceutical (3)
Phase 1 (1513)
Phase 2 (1742)
Phase 3 (934)
Pipeline (577)
Policy (17)
Postmarket research (30)
Preclinical (654)
Press Release (2)
Prostate cancer (8)
Psychedelics (4)
Radiopharmaceuticals (17)
Rare diseases (78)
Real estate (425)
Recruiting (5)
Regulatory (947)
Reports (7)
Research institute (150)
Resumes & cover letters (9)
Rett syndrome (1)
RNA editing (5)
RSV (2)
Schizophrenia (17)
Series A (51)
Series B (25)
Service/supplier (2)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (3)
Sponsored (1)
Startups (500)
Stomach cancer (3)
Supply chain (6)
Tariffs (2)
The Weekly (5)
Vaccines (57)
Venture capital (16)
Weight loss (27)
Women's health (14)
Worklife (1)
Date
Last 7 days (63)
Last 30 days (243)
Last 365 days (2414)
2026 (769)
2025 (2438)
2024 (2608)
2023 (2858)
2022 (3751)
2021 (4048)
2020 (3471)
2019 (2061)
2018 (1554)
2017 (1795)
2016 (1624)
2015 (1835)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
Location
Africa (45)
Alabama (3)
Arizona (20)
Asia (1975)
Australia (308)
California (1807)
Canada (283)
China (98)
Colorado (64)
Connecticut (17)
Delaware (8)
Europe (4071)
Florida (69)
Georgia (13)
Hawaii (2)
Idaho (3)
Illinois (25)
India (3)
Indiana (68)
Japan (20)
Kansas (15)
Kentucky (1)
Maryland (63)
Massachusetts (636)
Michigan (14)
Minnesota (25)
Mississippi (1)
Missouri (6)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (149)
New York (91)
North Carolina (146)
Northern California (907)
Ohio (53)
Oklahoma (2)
Oregon (7)
Pennsylvania (129)
Puerto Rico (1)
Rhode Island (3)
South America (40)
South Carolina (2)
Southern California (733)
Tennessee (5)
Texas (175)
United States (3628)
Utah (5)
Virginia (14)
Washington D.C. (3)
Washington State (104)
West Virginia (1)
Wisconsin (15)
40,647 Results for "akoya biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Quanterix and Akoya Biosciences Announce Amended Merger Agreement
April 29, 2025
·
10 min read
Press Releases
Akoya Biosciences Reports First Quarter 2025 Financial Results
May 13, 2025
·
11 min read
Business
Akoya Biosciences Reports First Quarter 2024 Financial Results
Akoya Biosciences, Inc., The Spatial Biology Company®, announced its financial results for the first quarter ending March 31, 2024.
May 13, 2024
·
11 min read
Press Releases
Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition
March 4, 2025
·
11 min read
Press Releases
Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum
July 9, 2025
·
5 min read
Policy
Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical WorkflowsKR-HT5 is based on Akoya’s PhenoImager® HT Platform
Akoya Biosciences, Inc., The Spatial Biology Company®, and Shanghai KR Pharmtech have jointly announced that KR-HT5, which Akoya Biosciences co-developed with Shanghai KR Pharmtech utilizing the PhenoImager HT technology as its foundation, has received premarket approval from China’s National Medical Products Administration to support next generation pathology clinical workflows.
May 2, 2024
·
4 min read
Genetown
Akoya Biosciences Names BostonGene as a Qualified CRO Service Provider
BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, announced that it has been named as a qualified contract research organization of Akoya Biosciences.
March 19, 2024
·
3 min read
Genetown
Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients
Akoya Biosciences, Inc., The Spatial Biology Company®, and NeraCare, a leading developer of laboratory tests for the prognosis of melanoma patients, announced an exclusive agreement under which the parties will develop market opportunities for combining Akoya’s PhenoImager HT platform and NeraCare’s Immunoprint assay for patient stratification and therapy selection in early-stage melanoma patients.
May 9, 2024
·
5 min read
Business
Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts
Akoya Biosciences, Inc., The Spatial Biology Company®, has opened its Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts to meet the accelerating demand for its spatial biology solutions and the increased utilization of the company’s PhenoCycler®-Fusion and the PhenoImager® HT platforms.
May 6, 2024
·
4 min read
Press Releases
Akoya Biosciences Selects Argonaut Manufacturing Services as IVD Manufacturing Partner
January 28, 2025
·
5 min read
1 of 4,065
Next
